Our website uses necessary cookies to enable basic functions and optional cookies to help us to enhance your user experience. Learn more about our cookie policy by clicking "Learn More".
Accept All Only Necessary Cookies
PharmaShots icon

2.0.2 by Octavus Consulting Pvt. Ltd.


May 15, 2022

About PharmaShots

Incisive Life Sciences news in 3 shots.

PharmaShots provides real-time summarised News in 3 shots from Pharma, Biotech, Med-Tech, Digital Health, and Life Sciences industry readable in 60 seconds. You will have top Life Sciences trending news, curated by industry analysts and KOL interviews at your fingertips.

The Future of Reading Life Sciences News is Here.

• Hand-picked: Top Life Sciences news at one platform

• Concise: Summarised news in 3 shots

• Swift: Readable in 60 seconds

• Reliable: Trusted news from authentic sources

Features:

• Summarised content

• Curated by industry analysts

• Customized News

• Targeted WW news coverage

• One Stop Shop

• Easy Accessibility

• Reliable

Benefits:

• Repository for intelligence from news sources

• Access to all relevant, customised news anytime

• Life Sciences news at your fingertips

• Top 20: Retrospective analysis and reports

• Insights+: Insightful analysis reports

• Viewpoints: KOL articles and interviews

Translation Loading...

Additional APP Information

Latest Version

Request PharmaShots Update 2.0.2

Requires Android

4.4 and up

Available on

Get PharmaShots on Google Play

Show More

What's New in the Latest Version 2.0.2

Last updated on May 15, 2022

Minor bug fixes and improvements. Install or update to the newest version to check it out!

Show More

PharmaShots Screenshots

Comment Loading...
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Subscribed Successfully!
You're now subscribed to APKPure.
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Success!
You're now subscribed to our newsletter.